Q4 2015 Holdings
Filed 2016-02-16 | 57 holdings | $15.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.7M | 50,222 | 29.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.6M | 43,870 | 28.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.2M | 10,482 | 20.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.2M | 34,000 | 13.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $1.0M | 100,000 | 6.5% |
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $10.7K | 31,600 | 0.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.9K | 87,415 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $6.3K | 102,459 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $6.3K | 32,969 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $5.9K | 348,583 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $5.8K | 10,714 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $5.8K | 35,773 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $5.7K | 47,956 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $5.7K | 127,088 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.3K | 77,100 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $5.2K | 41,662 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.2K | 48,045 | 0.0% |
| Merck & Co Inc New(MRK) | COM | 58933Y105 | $4.8K | 90,000 | 0.0% |
| Qiagen NV(QGEN) | REG SHS | N72482107 | $4.4K | 160,000 | 0.0% |
| Medivation Inc | COM | 58501N101 | $4.4K | 91,310 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $4.3K | 22,643 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $3.4K | 33,700 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $3.3K | 9,700 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $2.3K | 80,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $2.2K | 135,627 | 0.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $1.9K | 48,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $1.8K | 50,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.7K | 60,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $1.7K | 49,100 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $1.5K | 102,200 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $1.5K | 19,110 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $1.4K | 95,700 | 0.0% |
| Ignyta Inc | COM | 451731103 | $1.3K | 100,000 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $1.3K | 17,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $1.3K | 90,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.2K | 100,000 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $1.2K | 33,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.1K | 60,000 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $1.1K | 100,000 | 0.0% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $1.1K | 14,919 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.0K | 6,514 | 0.0% |
| Merrimack Pharmaceuticals in | COM | 590328100 | $968 | 122,500 | 0.0% |
| Medicines Co | COM | 584688105 | $934 | 25,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $929 | 30,000 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $857 | 332,157 | 0.0% |
| Novavax IncCall | COM | 670002104 | $839 | 100,000 | 0.0% |
| Novavax IncPut | COM | 670002104 | $839 | 100,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $795 | 60,000 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $757 | 70,000 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $693 | 56,788 | 0.0% |